Lessons learned from implementing in AI at regulated medical device manufacturer, ResMed. This includes top 5 challenges and ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

BSX carries a Zacks Rank #2 (Buy), while RMD has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

Fintel reports that on December 18, 2025, Stifel maintained coverage of ResMed (NYSE:RMD) with a Hold recommendation. Analyst ...

ResMed (RMD) has quietly drifted lower over the past week, but the stock is still up this year, which raises a straightforward question for investors: is this dip an opportunity or a warning? See our ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...

Another Australian stock to buy and hold for 10 years is ResMed. It has spent decades building a dominant position in sleep ...

Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44 th Annual J.P. Morgan Healthcare ...

Fintel reports that on December 18, 2025, Stifel maintained coverage of ResMed Inc. - Depositary Receipt (OTCPK:RSMDF) with a Hold recommendation. Analyst Price Forecast Suggests 68.11% Upside As of ...